Cue Biopharma shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Cue Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Cue Biopharma held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cue Biopharma by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $154k | 58k | 2.64 |
| 2023-09-30 | $44k | 19k | 2.30 |
| 2023-06-30 | $64k | 18k | 3.65 |
| 2023-03-31 | $50k | 14k | 3.57 |
| 2022-12-31 | $40k | 14k | 2.85 |
| 2022-06-30 | $374k | 150k | 2.49 |
| 2022-03-31 | $735k | 151k | 4.88 |
| 2021-12-31 | $1.7M | 152k | 11.31 |
| 2021-09-30 | $3.4M | 234k | 14.57 |
| 2021-03-31 | $7.3M | 602k | 12.20 |
| 2020-12-31 | $6.4M | 513k | 12.51 |
| 2020-09-30 | $5.1M | 338k | 15.05 |
| 2020-06-30 | $8.1M | 331k | 24.51 |
| 2018-06-30 | $147k | 12k | 11.86 |